Brian Harvey

researcher

Brian Harvey is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-9864-7894
P1153Scopus author ID7103106766

P166award receivedMember of the Academy of Science of South AfricaQ75746002
P69educated atNorth West University School of PharmacyQ99289672
P108employerNorth-West UniversityQ1998811
North West University School of PharmacyQ99289672
P734family nameHarveyQ19767733
HarveyQ19767733
HarveyQ19767733
P735given nameBrianQ15930574
BrianQ15930574
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q26786354A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates
Q39270596A brain-behaviour initiative for South Africa: the time is right
Q58554477A critical inquiry into marble-burying as a preclinical screening paradigm of relevance for anxiety and obsessive-compulsive disorder: Mapping the way forward
Q49019840A high-fat diet exacerbates depressive-like behavior in the Flinders Sensitive Line (FSL) rat, a genetic model of depression.
Q41204071A novel hypothesis for the psycho-modulating effects of lithium: the role of essential fatty acids, eicosanoids and sub-cellular second messengers
Q38678845A psycho-behavioral perspective on modelling obsessive-compulsive disorder (OCD) in animals: The role of context
Q46481081A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia.
Q92706369Abnormal repetitive behaviors in zebrafish and their relevance to human brain disorders
Q59180546Absence of an effect of the lithium-induced increase in cyclic GMP on the cyclic GMP-stimulated phosphodiesterase (PDE II). Evidence for cyclic AMP-specific hydrolysis
Q59180527Acid-dependent dismutation of nitrogen oxides may be a critical source of nitric oxide in human macrophages
Q89266437Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs
Q48868088An inhibitor of cAMP-dependent protein kinase induces behavioural and neurological antidepressant-like effects in rats
Q91827157Animal models of major depressive disorder and the implications for drug discovery and development
Q43016466Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression.
Q40083764Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies.
Q48736233Attenuated brain-derived neurotrophic factor and hypertrophic remodelling: the SABPA study
Q47704119Azure B and a synthetic structural analogue of methylene blue, ethylthioninium chloride, present with antidepressant-like properties
Q34242887Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase.
Q51875231Brain-derived neurotrophic factor: the neurotrophin hypothesis of psychopathology.
Q46491313Central effects of the preservative, methylparaben. In vivo activation of cAMP-specific phosphodiesterase and reduction of cortical cAMP.
Q40357417Chronic depression symptoms and salivary NOx are associated with retinal vascular dysregulation: The SABPA study
Q43553242Chronic inositol increases striatal D(2) receptors but does not modify dexamphetamine-induced motor behavior. Relevance to obsessive-compulsive disorder
Q48646458Chronic treatment with the phosphodiesterase type 5 inhibitors sildenafil and tadalafil display anxiolytic effects in Flinders Sensitive Line rats.
Q46907237Cortical/hippocampal monoamines, HPA-axis changes and aversive behavior following stress and restress in an animal model of post-traumatic stress disorder
Q46000254Cortico-striatal cyclic AMP-phosphodiesterase-4 signalling and stereotypy in the deer mouse: attenuation after chronic fluoxetine treatment.
Q39772759Cortico-striatal oxidative status, dopamine turnover and relation with stereotypy in the deer mouse
Q48636177Corticolimbic changes in acetylcholine and cyclic guanosine monophosphate in the Flinders Sensitive Line rat: a genetic model of depression.
Q34537344Defining the neuromolecular action of myo-inositol: application to obsessive-compulsive disorder
Q38840746Depression Symptoms Facilitated Fibrinolytic Dysregulation and Future Coronary Artery Disease Risk in a Black Male Cohort: The Sympathetic Activity and Ambulatory Blood Pressure in Africans Study
Q44407497Depression, cardiometabolic function and left ventricular hypertrophy in African men and women: the SABPA study
Q35418546Depressive Symptoms and 24-Hour Ambulatory Blood Pressure in Africans: The SABPA Study
Q39720514Depressive symptoms and sub-clinical atherosclerosis in Africans: role of metabolic syndrome, inflammation and sympathoadrenal function
Q48679497Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma.
Q40322822Dissociation between learning and memory impairment and other sickness behaviours during simulated Mycoplasma infection in rats
Q39131249Distinct intrinsic functional brain network abnormalities in methamphetamine-dependent patients with and without a history of psychosis
Q42487035Early life trauma decreases glucocorticoid receptors in rat dentate gyrus upon adult re-stress: reversal by escitalopram
Q43624338Early suppression of striatal cyclic GMP may predetermine the induction and severity of chronic haloperidol-induced vacous chewing movements
Q58701199Efavirenz exposure, alone and in combination with known drugs of abuse, engenders addictive-like bio-behavioural changes in rats
Q59180469Effect of Chronic N-Acetyl Cysteine Administration on Oxidative Status in the Presence and Absence of Induced Oxidative Stress in Rat Striatum
Q40542165Effects of myo-inositol versus fluoxetine and imipramine pretreatments on serotonin 5HT2A and muscarinic acetylcholine receptors in human neuroblastoma cells
Q57476891Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial
Q44546959Endocrine, cognitive and hippocampal/cortical 5HT 1A/2A receptor changes evoked by a time-dependent sensitisation (TDS) stress model in rats
Q92966514Esketamine and rapastinel, but not imipramine, have antidepressant-like effect in a treatment-resistant animal model of depression
Q48146372Evidence that lithium induces a glutamatergic: nitric oxide-mediated response in rat brain
Q39786914Excessive nest building is a unique behavioural phenotype in the deer mouse model of obsessive-compulsive disorder
Q48043296Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression I: bio-behavioural validation and response to imipramine
Q39333515Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies
Q40016188Facilitated defensive coping, silent ischaemia and ECG left-ventricular hypertrophy: the SABPA study
Q44466175Fluoxetine decreases stereotypic behavior in primates
Q46199482Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: a bio-behavioral study in the Flinders Sensitive Line rat.
Q48463420Increased hippocampal nitric oxide synthase activity and stress responsiveness after imipramine discontinuation: role of 5HT 2A/C-receptors
Q48509791Increased stress-evoked nitric oxide signalling in the Flinders sensitive line (FSL) rat: a genetic animal model of depression
Q43179729Investigating the role of protein kinase-G in the antidepressant-like response of sildenafil in combination with muscarinic acetylcholine receptor antagonism
Q46506420Involvement of the NMDA receptor, NO-cyclic GMP and nuclear factor K-beta in an animal model of repeated trauma
Q59180434Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administration
Q59209440Ketamine and rapidly acting antidepressants: Breaking the speed of sound or light?
Q51164484Late-life effects of chronic methamphetamine exposure during puberty on behaviour and corticostriatal mono-amines in social isolation-reared rats.
Q41199206Lithium modulation of cortical cyclic nucleotides: evidence for the Yin-Yang hypothesis
Q42528653Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity
Q38988277Long-lasting effects of fluoxetine and/or exercise augmentation on bio-behavioural markers of depression in pre-pubertal stress sensitive rats.
Q48036863Long-term effects of pre-pubertal fluoxetine on behaviour and monoaminergic stress response in stress-sensitive rats.
Q46916643Metabolic and glutathione redox markers associated with brain-derived neurotrophic factor in depressed african men and women: evidence for counterregulation?
Q89431730Methylene Blue Analogues with Marginal Monoamine Oxidase Inhibition Retain Antidepressant-like Activity
Q46327960Methylene blue and its analogues as antidepressant compounds.
Q46017960N-Acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats.
Q46265873N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges.
Q44000229NMDA receptor involvement in imipramine withdrawal-associated effects on swim stress, GABA levels and NMDA receptor binding in rat hippocampus
Q35587678Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression
Q59180403Neurochemical differences in two rat strains exposed to social isolation rearing.
Q38385469Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development.
Q38209914Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries
Q48399834Neuroscience in Africa
Q38238790New insights on the antidepressant discontinuation syndrome.
Q38832138Obsessive-compulsive disorder: Insights from animal models
Q39965166Of mice and marbles: Novel perspectives on burying behavior as a screening test for psychiatric illness
Q41067906Ozone exposure of Flinders Sensitive Line rats is a rodent translational model of neurobiological oxidative stress with relevance for depression and antidepressant response
Q48205980Ozone modulates the effects of imipramine on immobility in the forced swim test, and nonspecific parameters of hippocampal oxidative stress in the rat.
Q92504499Pathological Consequences of Drug Abuse: Implication of Redox Imbalance
Q47566821Peromyscus maniculatus bairdii as a naturalistic mammalian model of obsessive-compulsive disorder: current status and future challenges
Q40660866Prospective analysis of the medicine possession ratio of antidepressants in the private health sector of South Africa, 2006 - 2011.
Q46734995Re: Less is more.
Q49061911Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density
Q44543537Role of aging and striatal nitric oxide synthase activity in an animal model of tardive dyskinesia
Q42941375Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues
Q45241979Serotonin and stress: protective or malevolent actions in the biobehavioral response to repeated trauma?
Q40307801Simulated systemic recurrent Mycoplasma infection in rats induces recurrent sickness responses without residual impairment in spatial learning and memory
Q44949920Single photon emission computed tomography (SPECT) in obsessive-compulsive disorder before and after treatment with inositol
Q40047762Social behavior in deer mice as a novel interactive paradigm of relevance for obsessive-compulsive disorder (OCD).
Q48610452Social isolation rearing in rats alters plasma tryptophan metabolism and is reversed by sub-chronic clozapine treatment.
Q46969074Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine.
Q64945674Social isolation rearing-induced anxiety and response to agomelatine in male and female rats: Role of corticosterone, oxytocin, and vasopressin.
Q46987238Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder
Q46262688Stress and re-stress increases conditioned taste aversion learning in rats: possible frontal cortical and hippocampal muscarinic receptor involvement
Q44892905Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus
Q46904550Studies into the anxiolytic actions of agomelatine in social isolation reared rats: Role of corticosterone and sex.
Q40624774Symmetry symptoms in obsessive-compulsive disorder: clinical and genetic correlates
Q64098164The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia
Q35001959The ampakine, Org 26576, bolsters early spatial reference learning and retrieval in the Morris water maze: a subchronic, dose-ranging study in rats.
Q43255590The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats
Q35424733The impact of HIV/AIDS on compliance with antidepressant treatment in major depressive disorder: A prospective study in a South African private healthcare cohort
Q46275462The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase
Q40306811The long-term effects of methamphetamine exposure during pre-adolescence on depressive-like behaviour in a genetic animal model of depression
Q50180949The monoamine oxidase inhibition properties of selected structural analogues of methylene blue
Q59180549The stimulatory effect of chronic lithium treatment on basal thyrotropin secretion in rats: In vivo antagonism by methylparaben
Q34950165The styrene metabolite, phenylglyoxylic acid, induces striatal-motor toxicity in the rat: influence of dose escalation/reduction over time
Q48039102The α2C-adrenoceptor antagonist, ORM-10921, exerts antidepressant-like effects in the Flinders Sensitive Line rat.
Q46515418The α2C-adrenoceptor antagonist, ORM-10921, has antipsychotic-like effects in social isolation reared rats and bolsters the response to haloperidol.
Q38635337Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective
Q28266002Tianeptine: a novel atypical antidepressant that may provide new insights into the biomolecular basis of depression
Q46669368Withdrawal-associated changes in peripheral nitrogen oxides and striatal cyclic GMP after chronic haloperidol treatment

Search more.